cefdinir (Omnicef)
Drug2.5 ml of strawberry cream flavored oral suspension 125 mg/5 ml
Other names: ABT-198, Omnicef, cefdinir
NCT Number: NCT00644774
To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.
Looking for future studies?
Notify Me4 year–8 year
All sexes
Interventional
Phase 4
Scottsdale, Arizona, United States
The Primary Purpose for the study is "Other". Per ClinicalTrias.gov, more information regarding the primary purpose is described here; this study is a pediatric taste test.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2.5 ml of strawberry cream flavored oral suspension 125 mg/5 ml
Other names: ABT-198, Omnicef, cefdinir
2.5 ml of cherry flavored oral suspension 100 mg/5 ml
Other names: Zithromax
Time frame: 2 hours
Time frame: 72 hours with follow-up to a satisfactory conclusion
Time frame: 72 hours
Time frame: 2 hours
Time frame: 2 hours with follow-up to a satisfactory conclusion
Abbott
Industry
A Comparative, Multi-Center, Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06840925
Healthy
Melbourne, Victoria, Australia
View Trial DetailsNCT01866852
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT05370222
Behavior, Behavior, Animal
Clermont-Ferrand, AURA, France
View Trial DetailsNCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial Details